Floatz logo

Therapeutic Asset Ratings

344 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Multiple Myeloma
Janssen Research & Development, LLCP4BB (68)
Inno-206
Multiple Myeloma
GlaxoSmithKlineP4BB (68)
PREDNISONE TABLETS
Multiple Myeloma
GlaxoSmithKlineP4BB (68)
Thalidomide
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, ChinaP4BB (68)
Bortezomib
Multiple Myeloma
Universitätsklinikum Hamburg-EppendorfP4BB (67)
Busulphan
Multiple Myeloma
SCRI Development Innovations, LLCP4BB (67)
Carfilzomib
Multiple Myeloma
National Cancer Institute (NCI)P4BB (67)
cc-5013
Multiple Myeloma
Universitätsklinikum Hamburg-EppendorfP4BB (67)
Cyclophosphamide
Multiple Myeloma
Fred Hutchinson Cancer CenterP4BB (67)
DARATUMUMAB
Multiple Myeloma
Janssen Research & Development, LLCP4BB (67)
DEXAMETHASONE
Multiple Myeloma
Universitätsklinikum Hamburg-EppendorfP4BB (67)
Evomela
Multiple Myeloma
Dana-Farber Cancer InstituteP4BB (67)
FILGRASTIM
Multiple Myeloma
Janssen Research & Development, LLCP4BB (67)
Pomalidomide
Multiple Myeloma
National Cancer Institute (NCI)P4BB (67)
Elranatamab
Multiple Myeloma
Anne Louise Tølbøll SørensenP4BB (66)
Isatuximab
Multiple Myeloma
Universitätsklinikum Hamburg-EppendorfP4BB (66)
Linvoseltamab
Multiple Myeloma
Anne Louise Tølbøll SørensenP4BB (66)
Mezigdomide
Multiple Myeloma
SCRI Development Innovations, LLCP4BB (66)
mln9708
Multiple Myeloma
Navy General Hospital, BeijingP4BB (66)
Talquetamab
Multiple Myeloma
Anne Louise Tølbøll SørensenP4BB (66)
Teclistamab
Multiple Myeloma
Anne Louise Tølbøll SørensenP4BB (66)
Benadryl
Multiple Myeloma
SCRI Development Innovations, LLCP4BB (65)
ETOPOSIDE
Multiple Myeloma
The Affiliated People's Hospital of Ningbo UniversityP3BB (65)
HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS T CELLS FOR CELL-BASED GENE THERAPY. CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE SELF-INACTIVATING (SIN) HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) BASED LENTIVIRAL VECTOR (LVV) PSEUDOTYPED WITH THE VESICULAR STOMATITIS VIRUS GLYCOPROTEIN G (VSV-G) ENVELOPE PROTEIN, AND ENCODING THE C11D5.3 ANTI-TNF RECEPTOR SUPERFAMILY MEMBER 17 (TNFRSF17, BCMA) SINGLE CHAIN VARIABLE FRAGMENT (SCFV) CD8/4-1BB/CD3ZETA CHIMERIC ANTIGEN RECEPTOR (CAR) UNDER THE TRANSCRIPTIONAL CONTROL OF THE MYELOPROLIFERATIVE SARCOMA VIRUS ENHANCER, NEGATIVE CONTROL REGION DELETED, DL587REV PRIMER-BINDING SITE SUBSTITUTED (MND) PROMOTE
Multiple Myeloma
Memorial Sloan Kettering Cancer CenterP3BB (65)
Fludarabine
Multiple Myeloma
Fred Hutchinson Cancer CenterP4BB (64)
Showing 1 to 25 of 344 assets
PreviousPage 1 of 14Next